DataMEDS AI Unveils New Corporate Website Following Acquisition and Litigation Settlement
DataMEDS AI has launched its new corporate website, www.DataMedsAI.com. This change follows the company's recent acquisition of Helomics Corporation's artificial intelligence (AI) Cancer Diagnostics Lab from Axe Compute and a litigation settlement that resulted in ~$19 million in liabilities being extinguished from DataMEDS' balance sheet.
Gerald E. Commissiong, Interim Co-CEO of DataMEDS, said: 'With the previously disclosed closing of the Helomics Corporation acquisition and settlement of litigation related to the May 11, 2023 acquisition of Wellgistics, LLC., we are now poised to launch our Health Lives Here consumer application as we begin telling the DataMEDS story to the broader market.'
The company's new corporate website is part of its AI-centric marketing efforts, aimed at getting organic traction online and drawing earned media interest in their story. DataMEDS plans to soft-launch the Health Lives Here app shortly.